ImageneBio Insider Trades
NASDAQ: IMAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 1 · $95.84K
- Sales
- 2 · $17.33K
- Shares bought / sold
- 16.00K / 3.20K
- Net activity
- Net buying $78,506
ImageneBio insider activity
Over the last 12 months, ImageneBio insiders reported 10 transactions on SEC Form 4: 1 open-market purchase and 2 sales. Insiders bought $95,840 and sold $17,334 worth of stock, for net insider buying of $78,506. The largest seller was Lally Robert B, with $17,334 in reported sales.
The most recent filing shows Yarema Kristin (Chief Executive Officer) reporting a transaction in 254,800 shares on Aug 14, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put IMA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
IMA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 14, 2026 | Grant-Huerta YaninaChief Financial Officer | Award | 39,000 | — | Form 4 |
| Aug 14, 2026 | Grant-Huerta YaninaChief Financial Officer | Award | 65,000 | — | Form 4 |
| Aug 14, 2026 | Yarema KristinChief Executive Officer | Award | 254,800 | — | Form 4 |
| Jul 25, 2026 | Yarema KristinChief Executive Officer | other | 115,129 | — | Form 4 |
| Jul 25, 2026 | Yarema KristinChief Executive Officer | Option exercise | 38,376 | — | Form 4 |
| Jul 17, 2026 | Lally Robert BPrincipal Accounting Officer | Sale | 1,525 | $8.14K | Form 4 |
| Jul 16, 2026 | Lally Robert BPrincipal Accounting Officer | Sale | 1,671 | $9.19K | Form 4 |
| Mar 16, 2026 | Yarema KristinChief Executive Officer | Award | 85,400 | — | Form 4 |
| Dec 30, 2025 | Butler ErinPrincipal Accounting Officer | Award | 22,500 | — | Form 4 |
| Dec 24, 2025 | SLATTERY JOSEPH PDirector | Buy | 16,000 | $95.84K | Form 4 |
| Jul 28, 2025 | Marango JotinChief Financial Officer | Tax withholding | 4,630 | $79.45K | Form 4 |
| Jul 28, 2025 | Marango JotinChief Financial Officer | Award | 15,776 | — | Form 4 |
| Jul 25, 2025 | Butler ErinPrincipal Accounting Officer | Award | 3,051 | — | Form 4 |
| Jul 25, 2025 | Bonita David PDirector | Buy | 83,611 | $2.50M | Form 4 |
| Jul 25, 2025 | Bonita David PDirector | Option exercise | 379 | — | Form 4 |
| Jul 25, 2025 | Stampacchia OtelloDirector | Buy | 267,556 | $8.00M | Form 4 |
| Jul 25, 2025 | Stampacchia OtelloDirector | Option exercise | 379 | — | Form 4 |
| Jul 25, 2025 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLCDirector | Award | 83,611 | $208.19K | Form 4 |
| Jul 25, 2025 | Wang Jonathan JianDirector | Award | 971,173 | — | Form 4 |
| Jul 25, 2025 | Wang Jonathan JianDirector | Award | 143,832 | — | Form 4 |
| Jul 25, 2025 | Wang Stephen HuiDirector | Award | 12,535 | — | Form 4 |
| Jul 25, 2025 | Wang Stephen HuiDirector | Award | 50,144 | — | Form 4 |
| Jul 25, 2025 | Wang Stephen HuiDirector | Award | 188,042 | — | Form 4 |
| Aug 4, 2023 | Bonita David PDirector | Award | 153,121 | — | Form 4 |
| Aug 4, 2023 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLCDirector | Award | 153,121 | — | Form 4 |
| Aug 4, 2023 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLCDirector | Award | 153,121 | — | Form 4 |
| Aug 4, 2023 | Bonita David PDirector | Award | 153,121 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4